In line with our previous report on TRM cells in primary CRC [13], the CD103+CD8+ TRM cells in CRLM and the liver also had high expression of co-inhibitory markers, which indicate continuous T cell activation. This evidence concerns the gene CD8A and colorectal carcinoma.